Weight Loss Surgery in Adolescents With Extreme Obesity
YES
Effectiveness and Safety of Weight Loss Surgery in Adolescents With Extreme Obesity Within a Structured Pre- and Post-surgery Treatment Program, Subproject 3
4 other identifiers
observational
66
1 country
5
Brief Summary
The use of bariatric surgery in adolescents is controversial. On one side, bariatric surgery is the only effective treatment to achieve sustained weight loss in adults with extreme obesity. Comorbidities are reversed and mortality is reduced. In adolescents, bariatric surgery is equally effective; however, due to the paucity of long-term data, the long-term effects and risks are unknown. Thus, due to surgical risk and ethical implications, bariatric surgery is considered experimental in Germany. Nevertheless, case volumes are increasing. The aim of this study is to evaluate the benefits and risks of adolescent bariatric surgery in the context of a structured preparation and follow-up program. The study is a subproject of the study "Medical and psychosocial implications of adolescent extreme obesity - acceptance and effects of structured care" (DRKS00004172). At 5 German university centers (Ulm, Datteln, Berlin, Essen, Leipzig), youth who undergo bariatric surgery and are participants in the overall project will be enrolled in a structured preparation and follow-up program. The program is designed to improve adherence and compliance and will result in comprehensive follow-up data. In addition to the data gathered in the overall project, subjects participating in subproject 3 will undergo assessments pertinent to bariatric surgery, as proposed in the American Teen-LABS study (http://www.cincinnatichildrens.org/ research/divisions/t/teen-labs/default/). Comparison will be made with BMI matched adolescents who participate in the overall project but do not undergo bariatric surgery. In November 2014 recruitment for the overall project was completed. However, patients interested in bariatric surgery will still be recruited until September 2016. There assessment will be the same as for patients recruited earlier. However, in an amendment in December 2014, the frequency of assessment via questionnaire was reduced from biannually to annually. In addition, a travel reimbursement of 30€ for each study visit was implemented.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2013
Longer than P75 for all trials
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 22, 2013
CompletedStudy Start
First participant enrolled
November 1, 2013
CompletedFirst Posted
Study publicly available on registry
February 13, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2028
ExpectedMay 8, 2024
May 1, 2024
4.4 years
October 22, 2013
May 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
BMI change from baseline
1 year postoperative
Secondary Outcomes (13)
BMI
every 6 months for 9 years
changes in somatic comorbidity
every 12 months for 9 years
changes in psychosocial comorbidity
every 12 months for 9 years
changes in psychiatric comorbidity
every 12 months for 9 years
peri- und postoperative complications
every 12 months for 9 years
- +8 more secondary outcomes
Study Arms (2)
bariatric surgery group
subjects who participate in the overall project and undergo bariatric surgery
conservative care group
subjects who participate in the overall project and do not undergo bariatric surgery
Interventions
The intervention takes place in the clinical care setting. The decision for surgery is made by a multidisciplinary team, according to the international guidelines and the recommendations of the German working group on obesity (AGA, www.a.g.a.de). The choice of procedure is made on an individual basis taking into consideration patient inherent factors as well as the recommendations of the operating center. Operations are conducted at certified bariatric centers according to the policies of the German working group on bariatric surgery (CAADIP), and in the context of a structured preparation and follow-up program. The program is offered by a multidisciplinary team (pediatrician, endocrinologist, surgeon, dietician, psychologist/psychiatrist, social worker) and comprises preparation for and education about the surgery and expected lifestyle changes, as well as a structured, multidisciplinary follow-up plan. Subjects sign a contract agreeing to adhere to the recommended follow-up schedule.
Subjects will be seen by a trained study physician every 6 months. Stuctured health assessments will be conducted, and individual treatment recommendations will be made based on the patients motivation and ability(e.g. inpatient obesity rehab, exercise, dietary or behavioral intervention etc.)
Eligibility Criteria
Subjects will be recruited from a cohort of young adults and adolescents participating in the "Adolescents with extreme Obesity" Study.
You may qualify if:
- BMI ≥ 35 kg/m2 with severe comorbidity or BMI ≥ 40 kg/m2 with relevant comorbidity
- completed longitudinal growth
- stable social surroundings
- exhaustion of conservative treatment
- participation in the project "Adolescents with extreme Obesity"
- adequate compliance and adherence
You may not qualify if:
- treatable causative condition
- unstable medical, psychosocial or psychiatric comorbidity
- alcohol or drug abuse
- pregnancy
- contraindication for bariatric surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Prof. Dr. Martin Wabitschlead
- University of Witten/Herdeckecollaborator
- Charite University, Berlin, Germanycollaborator
- University of Leipzigcollaborator
- Universität Duisburg-Essencollaborator
Study Sites (5)
Ambulatory Obesity Program, Charité University, Berlin
Berlin, 13353, Germany
Vestische Kinderklinik, University of Witten/Herdecke
Datteln, Germany
University Duisburg-Essen
Essen, 45147, Germany
University Hospital Leipzig
Leipzig, 04103, Germany
Dept for Pediatrics and Adolescent Medicine, University of Ulm: Interdisciplinary obesity clinic
Ulm, 89075, Germany
Biospecimen
Samples of fasting plasma, serum, DNA, urine, visceral and subcutaneous fat will be retained.
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Martin Wabitsch, Prof. Dr. med.
University of Ulm
- PRINCIPAL INVESTIGATOR
Susanna Wiegand, Dr. med.
Charite University, Berlin, Germany
- PRINCIPAL INVESTIGATOR
Thomas Reinehr, Prof. Dr. med.
University of Witten/Herdecke
- PRINCIPAL INVESTIGATOR
Johannes Hebebrand, Prof. Dr. med.
Universität Duisburg-Essen
- PRINCIPAL INVESTIGATOR
Wieland Kiess, Prof. Dr. med.
University of Leipzig
- PRINCIPAL INVESTIGATOR
Reinhard Holl, Prof. Dr. med.
University of Ulm
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Division Chief Pediatric Endocrinology and Diabetology
Study Record Dates
First Submitted
October 22, 2013
First Posted
February 13, 2014
Study Start
November 1, 2013
Primary Completion
April 1, 2018
Study Completion (Estimated)
January 1, 2028
Last Updated
May 8, 2024
Record last verified: 2024-05